Table 3.

Comparison of characteristics of the trials

^*P value: sirolimus eluting stent vs paclitaxel eluting stent; ^†KAMIR, before propensity score matching; ^††KAMIR, after propensity score matching comparing the clinical outcomes in patients with sirolimus eluting stent and in patients with paclitaxel eluting stent; ^§KAMIR, comparing the clinical outcomes in patients with sirolimus eluting stent and in patients with zotarolimus eluting stent. BMS, bare metal stent; DES, drug eluting stent; ENDEAVOR, Randomized Comparison of Zotarolimus-Eluting and Paclitaxel-Eluting Stents in Patients with Coronary Artery Disease; GRACE, Global Registry of Acute Coronary Events; KAMIR, Korea Acute Myocardial Infarction Registry; KOMER-AMI, Korean Multicentre Endeavor-Acute Myocardial Infarction; MI, myocardial infarction; na; non-available; OR, odds ratio; PASSION, Paclitaxel-Eluting Stent Versus Conventional Stent in Myocardial Infarction with ST-segment Elevation trial; PES, paclitaxel eluting stent; RESEARCH/T-SEARCH, Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry; SCAAR, Swedish Coronary Angiography and Angioplasty Registry; SESAMI, Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction; TLR, target lesion revascularization; TVR, target vessel revascularization; TYPHOON, Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty; SES, sirolimus eluting stent; ZES, zotarolimus eluting stent.